RecruitingPhase 4NCT06514547
Vaccine Immunity and Inflammation in the Aging Person Living With HIV
Sponsor
Hennepin Healthcare Research Institute
Enrollment
250 participants
Start Date
Jul 8, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
This study will track immune responsiveness to conjugate pneumococcal vaccines over time to help determine how long protection from this vaccine lasts in individuals with chronic medical conditions (in this study - HIV) and with age.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Age\>=18 years
- HIV Diagnosis
- On Antiretroviral Therapy with HIV Viral Load\<200 within last year
- Age\>=18 years
- HIV Ag-Ab test negative
Exclusion Criteria9
- Other significant immunosuppressing condition
- Age\< 18 years
- Pregnancy (at enrollment)
- Contraindication to pneumococcal vaccination
- Known contraindication to non-clinical blood draws (severe anemia last hemoglobin \<8g/dl)
- Subjects who, in the opinion of the Investigator, may be non-adherent to study schedules or procedures.
- Adults unable to consent
- Individuals with impaired ability to consent
- Incarceration at time of enrollment
Interventions
BIOLOGICALConjugate Pneumococcal Vaccine 20 (PCV20)
Vaccine
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06514547
Related Trials
A Randomized Clinical Trial to Evaluate Solutions for the Management of Virologic Failure on TLD in Sub-Saharan Africa
NCT053737583 locations
First Time in Human Study of Long Acting VH4524184 Formulations
NCT063105512 locations
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
NCT0720254662 locations
Development and Evaluation of a Virtual Reality Tool for At-Risk Trauma-Exposed Young People
NCT058160831 location
Skeletal Muscle Energetics and Fatiguability in Older Individuals
NCT041420471 location